• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

配体诱导的A431细胞表皮生长因子受体激活主要通过自分泌途径发生,该途径作用于细胞表面的受体而非细胞内的受体。

Ligand-induced activation of A431 cell epidermal growth factor receptors occurs primarily by an autocrine pathway that acts upon receptors on the surface rather than intracellularly.

作者信息

Van de Vijver M J, Kumar R, Mendelsohn J

机构信息

Laboratory of Receptor Biology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

出版信息

J Biol Chem. 1991 Apr 25;266(12):7503-8.

PMID:2019581
Abstract

A431 cells express high numbers of epidermal growth factor (EGF) receptors and produce a ligand for these receptors, transforming growth factor-alpha (TGF-alpha). We have obtained evidence that the EGF receptors on these cells may be activated through an "autocrine" pathway by ligand and have investigated whether activation of phosphorylation of the receptor by the endogenously produced TGF-alpha occurs intracellularly or at the cell surface. When A431 cells were cultured under serum-free conditions, in the absence of exogenous ligand, EGF receptors were found to have a basal level of phosphorylation. When cells were labeled by culturing with 32Pi in the continuous presence of monoclonal antibodies that block binding of TGF-alpha to the EGF receptor, phosphorylation decreased to 30 +/- 10% of the basal level. This reduction could not be accounted for by the decrease in receptor content attributable to down-regulation and catabolism of EGF receptors that resulted from the binding of anti-receptor monoclonal antibodies. The reduction in receptor phosphorylation mediated by antibody was accompanied by the accumulation of increased levels of secreted TGF-alpha species in the culture medium. We also pulse-labeled A431 cells for 15 min with [35S]cysteine and immunoprecipitated the cell lysate with anti-phosphotyrosine antibody after various chase periods. Tyrosine-phosphorylated EGF receptor became detectable after 40 min of chase and reached a maximum after 4-6 h; these times are in agreement with the intervals required for EGF receptors to reach the cell surface after synthesis and then to achieve maximal expression. In addition, only the 170-kDa, mature EGF receptor species, and not the 160-kDa intracellular precursor, was immunoprecipitated with the anti-phosphotyrosine antibody. The results of these pulse-chase experiments and the finding that anti-receptor monoclonal antibody can block receptor phosphorylation suggest that activation of EGF receptors can result from the binding of an endogenous ligand (presumably TGF-alpha), which occurs at the cell surface and not during receptor biosynthesis and intracellular processing.

摘要

A431细胞表达大量表皮生长因子(EGF)受体,并产生这些受体的一种配体,即转化生长因子-α(TGF-α)。我们已获得证据表明,这些细胞上的EGF受体可能通过配体经“自分泌”途径被激活,并且研究了内源性产生的TGF-α对受体磷酸化的激活是发生在细胞内还是细胞表面。当A431细胞在无血清条件下培养,且不存在外源性配体时,发现EGF受体具有基础水平的磷酸化。当细胞在持续存在阻断TGF-α与EGF受体结合的单克隆抗体的情况下用32Pi培养进行标记时,磷酸化水平降至基础水平的30±10%。这种降低不能用由于抗受体单克隆抗体结合导致的EGF受体下调和分解代谢引起的受体含量减少来解释。抗体介导的受体磷酸化降低伴随着培养基中分泌的TGF-α种类水平的增加。我们还用[35S]半胱氨酸对A431细胞进行了15分钟的脉冲标记,并在不同的追踪期后用抗磷酸酪氨酸抗体对细胞裂解物进行免疫沉淀。追踪40分钟后可检测到酪氨酸磷酸化的EGF受体,4 - 6小时后达到最大值;这些时间与EGF受体合成后到达细胞表面然后达到最大表达所需的时间间隔一致。此外,用抗磷酸酪氨酸抗体免疫沉淀的只有170 kDa的成熟EGF受体种类,而不是160 kDa的细胞内前体。这些脉冲追踪实验的结果以及抗受体单克隆抗体可阻断受体磷酸化的发现表明,EGF受体的激活可能是由于内源性配体(可能是TGF-α)的结合,这种结合发生在细胞表面,而不是在受体生物合成和细胞内加工过程中。

相似文献

1
Ligand-induced activation of A431 cell epidermal growth factor receptors occurs primarily by an autocrine pathway that acts upon receptors on the surface rather than intracellularly.配体诱导的A431细胞表皮生长因子受体激活主要通过自分泌途径发生,该途径作用于细胞表面的受体而非细胞内的受体。
J Biol Chem. 1991 Apr 25;266(12):7503-8.
2
Tyrosine phosphorylation of GSalpha and inhibition of bradykinin-induced activation of the cyclic AMP pathway in A431 cells by epidermal growth factor receptor.表皮生长因子受体对A431细胞中GSα的酪氨酸磷酸化及缓激肽诱导的环磷酸腺苷途径激活的抑制作用
J Biol Chem. 1996 Dec 6;271(49):31098-105. doi: 10.1074/jbc.271.49.31098.
3
Inability of anti-epidermal growth factor receptor monoclonal antibody to block "autocrine" growth stimulation in transforming growth factor-secreting melanoma cells.抗表皮生长因子受体单克隆抗体无法阻断分泌转化生长因子的黑色素瘤细胞中的“自分泌”生长刺激。
J Biol Chem. 1984 Oct 10;259(19):11895-900.
4
Ligand induced internalization of epidermal growth factor receptors by A431 cells decreases at high cell densities in culture.在培养过程中,A431细胞中配体诱导的表皮生长因子受体的内化在高细胞密度时会减少。
Growth Factors. 1991;5(1):45-55. doi: 10.3109/08977199109000270.
5
Differential activation of ErbB receptors in the rat olfactory mucosa by transforming growth factor-alpha and epidermal growth factor in vivo.体内转化生长因子-α和表皮生长因子对大鼠嗅黏膜中ErbB受体的差异性激活作用。
J Neurobiol. 1998 Nov 5;37(2):199-210. doi: 10.1002/(sici)1097-4695(19981105)37:2<199::aid-neu1>3.0.co;2-f.
6
Antibody-induced epidermal growth factor receptor dimerization mediates inhibition of autocrine proliferation of A431 squamous carcinoma cells.抗体诱导的表皮生长因子受体二聚化介导了对A431鳞状癌细胞自分泌增殖的抑制。
J Biol Chem. 1994 Nov 4;269(44):27595-602.
7
Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.225种抗表皮生长因子受体单克隆抗体的二价和单价片段对表皮生长因子受体功能的阻断作用
Cancer Res. 1993 Sep 15;53(18):4322-8.
8
A431 cell variants lacking the blood group A antigen display increased high affinity epidermal growth factor-receptor number, protein-tyrosine kinase activity, and receptor turnover.缺乏A血型抗原的A431细胞变体显示出高亲和力表皮生长因子受体数量增加、蛋白酪氨酸激酶活性增强以及受体周转加快。
J Cell Biol. 1988 Sep;107(3):939-49. doi: 10.1083/jcb.107.3.939.
9
The expression of transforming growth factor alpha receptor protein and its activation in chicken ovarian granulosa cells of maturing follicles.转化生长因子α受体蛋白在鸡成熟卵泡卵巢颗粒细胞中的表达及其激活
Histochem J. 1998 Sep;30(9):647-56. doi: 10.1023/a:1003544926637.
10
Kinetics and regulation of the tyrosine phosphorylation of epidermal growth factor receptor in intact A431 cells.完整A431细胞中表皮生长因子受体酪氨酸磷酸化的动力学及调控
Mol Cell Biol. 1988 Mar;8(3):1345-51. doi: 10.1128/mcb.8.3.1345-1351.1988.

引用本文的文献

1
Coordinated dysregulation of cancer progression by the HER family and p21-activated kinases.HER家族与p21激活激酶对癌症进展的协同失调
Cancer Metastasis Rev. 2020 Sep;39(3):583-601. doi: 10.1007/s10555-020-09922-6. Epub 2020 Aug 21.
2
The CHORD protein CHP-1 regulates EGF receptor trafficking and signaling in and in human cells.CHORD 蛋白 CHP-1 调节 和人细胞中表皮生长因子受体的运输和信号转导。
Elife. 2020 Feb 13;9:e50986. doi: 10.7554/eLife.50986.
3
John Mendelsohn's journey in cancer biology and therapy.约翰·门德尔松在癌症生物学与治疗领域的历程。
Cancer Biol Ther. 2020 May 3;21(5):389-390. doi: 10.1080/15384047.2020.1712829. Epub 2020 Jan 23.
4
John Mendelsohn: A visionary scientist, oncologist and leader.约翰·门德尔松:一位有远见的科学家、肿瘤学家和领导者。
Genes Cancer. 2019;10(5-6):109-118. doi: 10.18632/genesandcancer.195.
5
Targeted Treatment Options of Recurrent Radioactive Iodine Refractory Hürthle Cell Cancer.复发性放射性碘难治性许特莱细胞癌的靶向治疗选择
Cancers (Basel). 2019 Aug 15;11(8):1185. doi: 10.3390/cancers11081185.
6
How low can you go?你能降到多低?
Elife. 2018 Jan 4;7:e33604. doi: 10.7554/eLife.33604.
7
Targeting polyIC to EGFR over-expressing cells using a dsRNA binding protein domain tethered to EGF.利用与表皮生长因子(EGF)相连的双链RNA结合蛋白结构域,将聚肌胞苷酸(polyIC)靶向表皮生长因子受体(EGFR)过表达细胞。
PLoS One. 2016 Sep 6;11(9):e0162321. doi: 10.1371/journal.pone.0162321. eCollection 2016.
8
The advent of precision therapy in gastrointestinal malignancies: Targeting the human epidermal growth factor receptor family in colorectal and esophagogastric cancer.胃肠道恶性肿瘤精准治疗的进展:靶向结直肠癌和食管胃癌中的人表皮生长因子受体家族
J Carcinog. 2014 Nov 27;13:13. doi: 10.4103/1477-3163.145609. eCollection 2014.
9
The FRET signatures of noninteracting proteins in membranes: simulations and experiments.膜中非相互作用蛋白质的荧光共振能量转移特征:模拟与实验
Biophys J. 2014 Mar 18;106(6):1309-17. doi: 10.1016/j.bpj.2014.01.039.
10
Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC.发现一种突变选择性共价EGFR抑制剂,可克服非小细胞肺癌中T790M介导的耐药性。
Cancer Discov. 2013 Dec;3(12):1404-15. doi: 10.1158/2159-8290.CD-13-0314. Epub 2013 Sep 24.